Preservation of Seminal Ejaculation during Endoscopic Surgery for Prostatic Enlargement
- Conditions
- Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
- Registration Number
- CTRI/2019/04/018557
- Lead Sponsor
- All India Institute of Medical Sciences Bhubaneswar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
a) Patients with active sexual life and ability to ejaculate.
b) Written informed consent.
c) Patients with benign prostatic hyperplasia with any one of the following:
c.1) Lower urinary tract symptoms who had failed standard medical therapy (alpha blockers, 5 alpha reductase inhibitors)
c.2) Recurrent urinary retention (drug-refractory)
c.3) Recurrent urinary tract infection
c.4) Recurrent hematuria
a) ASA Grade 3 or more.
b) Suspected or confirmed malignancy of prostate, upper or lower urinary tract.
c) Neurological diseases or neurogenic bladder and voiding dysfunction.
d) Concomitant urethral stricture.
e) Bilateral upper tract dilatation with or without elevation of creatinine.
f) Pelvic pain syndrome.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The ejaculatory and erectile function after ejaculation preserving and conventional transurethral resection of prostate.Timepoint: 1. Preoperatively <br/ ><br>2. 3 months after Surgery
- Secondary Outcome Measures
Name Time Method Ejaculation Projection ScoreTimepoint: 1. Preoperatively <br/ ><br>2. 3 months after Surgery;IPSS ScoreTimepoint: 1. Preoperatively <br/ ><br>2. 3 months after Surgery;Maximum Flow rate (Qmax) <br/ ><br>Timepoint: 1. Preoperatively <br/ ><br>2. 3 months after Surgery;Post Void ResidueTimepoint: 1. Preoperatively <br/ ><br>2. 3 months after Surgery